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A premature infant is at high risk for many complications and multiple morbidities. A
patent ductus arteriosus (PDA) is just one complication that often presents with prematurity and
can be a major cardiac defect creating variations of altered cardiac function and systemic
circulation. The severity of effects a PDA can produce depends on factors such as gestational
age of the infant, weight of the infant, size of the defect, and the overall health of the neonate.
This topic is significant in the medical field because infants born prematurely are seen to
have a high rate of their patent ductus arteriosis (PDA) not closing after birth resulting in
complications. When the PDA does not close, it produces left to right shunting of the blood in
the heart. Left to right shunting is associated with pulmonary congestion and decreased blood
flow to vital organs (Linder et al., 2010). Prior to the introduction of ibuprofen, the only
alternative to indomethacin was a surgical ligation. This includes a thoracotomy with potentially
serious complications including chylothorax, infections, respiratory compromise, and death,
which is why this should be considered the last option (Sekar & Corff, 2008).
Ibuprofen was introduced as an alternative medication to close the PDA, but it is not
being utilized in all institutions. The purpose of this project is to explore the use of ibuprofen as
the first line of treatment for the closure of the PDA in the neonatal population. Information
produced could aide in the development of a new standard of care in the neonatal intensive care
units. Explanation of ibuprofens safety and efficacy as well as why it may be preferable to
indomethacin will be supported.

Definition and Description of the Problem
A ductus arteriosus (DA) is a bridge or canal connecting the pulmonary artery to the
descending aorta during fetal life (Rowan & Grenville, 2004). This opening is vital during fetal
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circulation in order for a significant portion of the blood to bypass the pulmonary circulation and
shunt to the body and eventually back to the placenta to be reoxygenated (Sekar & Corff, 2008).
The placenta is considered the fetal lung during intrauterine life; therefore, only a small amount
of circulating blood enters the pulmonary circulation during development. During normal
transition of a term infant from intrauterine to postnatal life, this ductus closes between 24-96
hours of life as there is a decrease in pulmonary vascular resistance, smooth muscle constriction,
decreased production of prostacylin and prostaglandin I2, increased production of endothelin 1,
and an increase in acetylcholine and bradykinin (Toyer & Fox, 2004). In addition, there are
constricting properties of oxygen and an increase in this gas helps to constrict the ductus and
begin apoptosis or cell death.
The incidence of a persisting PDA can range from 10-60% of neonates inversely related
to gestational age and birth weight (Dani et al., 2000). In the premature infant, this closure may
be delayed or non-existent for many reasons. For instance, it can be that the pulmonary
resistance does not decrease enough due to the premature infants lack surfactant, the production
and/or secretion of hormones is not adequate to sustain ductal closure, or that premature neonates
are less sensitive to the constricting properties of oxygen and more sensitive to the dilating
properties of prostaglandins that remain in the circulation. When the DA does not close
postnatally, it produces left to right shunting of the blood as mentioned above due to the increase
in systemic pressure and decrease in pulmonary vascular resistance (Linder et al., 2010). This
means the blood flowing from the left ventricle to the systemic circulation via the aorta, shunts
across the patent ductus arteriosus back into the pulmonary circulation. This shunting results in
increase pulmonary blood flow and decreased systemic blood flow; therefore, less blood flow to
other vital organs. This can create very serious complications including, but not limited to,
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pulmonary congestion, renal dysfunction, intraventricular hemorrhage (IVH), and
gastrointestinal perforation resulting in necrotizing enterocolitis (NEC) (Heyman, 2003). The
figure below allows a visualization of where this shunting takes place.

Fig. 1. Murphy, P.J. (2011). The Fetal Circulation

Review of Evidenced-Based Literature
The databases used within the St. Catherine University Library website were: CINAHL,
Medline, Cochrane review, and Google scholar. Within these databases, the keywords:
ibuprofen, neonatal population, and patent ductus arteriosis (PDA) were used. The timeframe
used in the search was 2000-2011. Five single studies and two meta-analysis were chosen to be
analyzed which compared indomethacin to ibuprofen in terms of their efficacy and adverse
effects.
The five single center studies reviewed all had similar purposes. They were to compare
the efficacy and safety of ibuprofen versus indomethacin in the treatment of the PDA in a
neonate. The efficacy was determined by whether or not the PDA closed with the appointed
treatment. Safety referred to the side effects or complications seen as a result of taking a
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particular medication. Within the five articles being used to investigate this topic, two different
research designs were seen. Three studies used randomized control trials (RCTs) and examined
the outcomes prospectively (Lago et al., 2002; Overmeire et al., 2000; Su et al., 2007), and two
used retrospective comparative studies (Katakam et al., 2007; Linder et al., 2010). RCTs are
considered an experimental design, which is the strongest method to examine causality. With
these studies being conducted in an institution allows for more control over variables, increasing
the validity of the results (Burns & Grove, 2009). The studies used random assignment,
spreading out the extraneous variables, adding to the validity of the results. The retrospective
comparative studies examined information in the charts of neonates whom had previously
received either ibuprofen or indomethacin to measure effectiveness and safety.
Power analysis was done in all of the RCTs, making the sample sizes appropriate in order
to improve the external validity, making the results generalizable (Lago et al., 2002; Overmeire
et al., 2000; Su et al., 2007). In the retrospective study done by Linder et al. (2010), a power
analysis was also performed validating the sample size, but it was not mentioned to have been
done in the study conducted by Katakam et al. (2007). By using inclusion and exclusion criteria
along with random assignment increases the strength of the sampling strategy and
generalizability of the findings.
The independent variables or treatment in these studies are the medications:
indomethacin and ibuprofen. In all of the studies, the closure of the PDA was the primary
dependent variable of concern. Adverse effects and morbidities became additional dependent
variables analyzed. Some of the most frequent adverse effects seen were: decreased renal
function, thrombocytopenia, increase in intraventricular hemorrhage (IVH), necrotizing
enterocolitis (NEC), bronchopulmonary dysplasia (BPD), sepsis, increase length of stay, and
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death. The three RCTs used the same standard dosing amounts and schedules with each
medication. Using the same type, amount, and frequency of medication increases the validity
and generalizability of the results. All five studies used the same type of strategies to measure
particular outcomes. For example, they all used echocardiography to monitor the PDA, lab
values to monitor renal function, thrombocytopenia, etc., and cranial ultrasounds to monitor for
IVH, and so on. This makes all of the study results very comparable.
In the five single center studies conducted, there was no statistical significance in the
closure of the PDA after receiving ibuprofen versus indomethacin. However, in all of the
literature, excluding the study conducted by Linder et al. (2010), there were statistically
significant renal effects. These studies found that indomethacin produced an increased incidence
of oliguria (p = 0.017- p=0.13) and an increase in serum creatinine (p= 0.03 - p= 0.04). In the
study by Linder et al. (2010), indomethacin was also found to produce a statistically significant
increase in thrombocytopenia (p < 0.007). All other outcomes analyzed such as NEC, IVH,
BPD, and mortality rates were found to be non-significant.
After the five smaller studies were reviewed, two larger meta-analysis were reviewed.
One analysis was by Thomas et al. (2004) comparing ibuprofen and indomethacin for the closure
of the patent ductus arteriosus and the other analysis was a Cochrane review published by
Ohlsson et al (2010) looking at “ibuprofen for the treatment of the patent ductus arteriosus in
preterm and/or low birth weight infants.” The first analysis was a compilation of nine studies,
which found similar results of the previous single center studies. That being that there was no
statistical significant between the two medication for closing the PDA; however, there is
statistically significant results in adverse effects as previously mentioned (Thomas et al., 2004).
Five of these nine trials found a statistically significant increase in serum creatinine
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concentration (p < 0.001), and statistically significant decreased urine output levels in the
indomethacin group (p < 0.001). This study also examined chronic lung disease as defined by

neonates requiring oxygen after 28 days postnatally and found this to be a more common finding
in the ibuprofen group (p < 0.05) (Thomas et al., 2004). In this study, other adverse outcomes
such as necrotizing enterocolitis, intraventricular hemorrhage, sepsis, retinopathy of prematurity,
periventricular leukomalacia, and re-opening of the PDA were not found to be statistically
significant.
The Cochrane Collaboration meta-analysis conducted by Ohlsson et al. (2010) also
compiled results from twenty different studies. One of these studies compared ibuprofen to a
placebo and not indomethacin, so these results will not be included. The criteria for these studies
were based on the type of study (randomized or quasi-randomized controlled trials), and the age
or weight of the participants (preterm infants < 37 weeks gestation or low birth weight of < 2500
grams) with a PDA confirmed by echocardiogram. Once again, there were no statistically
significant differences in the findings with regards to the closure of the PDA, mortality, need for
surgical ligation, reopening of the ductus, ROP, IVH, sepsis, or length of hospital stay. There
was; however, statistical significance with regards to the incidence of decreased urine output in
the indomethacin group (p = 0.006) and increase in serum creatinine (p < 0.01 – p = 0.07).

Implications for Practice
The effects of a patent ductus arteriosus on a neonate can range from mild to severe
effects. The most likely event to occur if the ductus does not close on it’s own or with the help
of a prostaglandin inhibiting medication or surgical ligation is that the pulmonary blood flow will
become too much for the neonate to handle leading to a back up of blood into the heart creating
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congestive heart failure (CHF) (Avery, 2005). Once the baby has CHF, this can lead to
numerous other complications and morbidities.
The medical implications to discuss are the two statistically significant findings when
using indomethacin instead of ibuprofen and those are decreased urine output (oliguria) and
increased serum creatinine. Decreased urine output can be a result of decreased renal blood
flow, acute tubular necrosis, and/or nephron dysgenesis (Avery, 2005). These are all negative
effects on the renal system and could potentially create permanent renal damage. The other
negative effect, which was statistically significant, was an increase in serum creatinine. Serum
creatinine is used as a measure of the glomerular filtration rate (GFR) in the neonate. GFR is a
function of the kidney that correlates well with the gestational age of the child. This means the

lower the gestation, the lower the GFR and visa versa. Giving indomethacin to preterm children
with premature glomerular filtration rates places the neonate at a disadvantage and can lead to
decreased urine output and decreased filtration of other substances of which would accumulate
and become nephrotoxic.

Parent Education
Parent education would be vital regarding the disease process, the available therapies, and
potential adverse reactions in all scenarios. The first topic of discussion would be regarding
what a PDA is and why it is required during fetal life, but how it can create additional illnesses
and complications if the ductus does not close postnatally. Then, it would be important to
support why there is a preference to first trial a medication versus the ligation even when there is
not a guarantee of ductal closure and there are additional risks of side effects when giving the
medication. The next important discussion would be regarding what medication will be used and
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why it is the preferred medication to a particular facility or providing practitioner. Then with

any medication being given, it would be important to discuss the potential adverse effects, which
could occur. After supporting a medication and thoroughly discussing the reasons behind giving
it, it is also important to discuss the possibility of needing the surgical ligation if the medication
did not produce the intended outcome.

Conclusion
There is sufficient evidence within the five individual studies and the two meta-analysis
reviewed that substantiate the results that the two medications have similar outcomes with
regards to closing the PDA. However, there are statistically significant side effects, particularly
effecting renal function when given indomethacin. This side effect alone is a strong argument
for a change in practice especially considering the population being neonates with already
fragile, immature systems. Given how ibuprofen produces less adverse effects, while producing
similar ductal closure results, is a clinical indication that it should be used in place of
indomethacin. Knowing that facilities throughout the country continue to use indomethacin
over ibuprofen when the two medications have comparable outcomes with ibuprofen producing
fewer side effects is why this topic should be researched more extensively. Providing these
statistics and findings will be important in order to promote change in a field that cares for some
of the most delicate patients.
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